CDG Invest Growth invests in the capital of companies in Morocco and Africa

CDG Invest Growth exits Steripharma, a pharmaceutical business in Morocco

CDG Invest Growth announced its exit from Laboratoires Steripharma, a well-established pharmaceutical business in Morocco through a strategic sale.

Steripharma was founded in 1999 and has since developed a large portfolio of drugs with strong recognition among patients and practitioners. The Company has its own range of medicines (generics) and also produces/distributes drugs under license for leading international laboratories. Its product range covers major therapeutic areas, including infectiology and parasitology, cardiology, respiratory system, digestive system, dental care, ophthalmology and dermatology.

Click here for more information about Steripharma

At an investment return of 4.6 money multiple, CDG Invest Growth has announced its successful exit from regional outsourcing company Intelcia, in favor of Altice group, a multinational group operating in telecommunications, content and media. « CDG Invest Growth has strongly contributed to Intelcia’s growth in Morocco and globally and has enhanced corporate governance culture » said […]

29 July 2021 CDG Invest Growth (“CIG”), the leading Morocco based private equity firm previously known as CDG Capital Private Equity, and Techniques Science-Santé (“T2S”), IM Alliance, Cyclopharma and Binarios (together, the “Company” or the “Group”) are pleased to announce the signing of an agreement for the sale of a majority stake in the largest […]

With an investment return of 3.3 money multiple, CDG Invest Growth has announced its total exit from Jet Contractors through a sale of shares on the Casablanca Stock Exchange. “CDG Invest Growth has contributed to the organic and structural development of Jet Contractors and has supported its integration of the value chain to become one […]